Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzocaine + lidocaine + tetracaine is a compounded topical anesthetic cream containing three local anesthetics—benzocaine (an ester-type), lidocaine (an amide-type), and tetracaine (an ester-type). It is primarily used to provide local dermal anesthesia for minor procedures such as laser hair removal, electrolysis, or other dermatological interventions. The mechanism of action involves reversible blockade of sodium ion channels in neuronal membranes, thereby inhibiting the initiation and conduction of nerve impulses and resulting in localized numbness or loss of sensation at the site of application. This combination is typically prepared by compounding pharmacies when commercial products are unavailable or unsuitable[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzocaine + lidocaine + tetracaine.